Compare ANL & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | EPSM |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | Cayman Islands | China |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.5M | 51.6M |
| IPO Year | 2022 | N/A |
| Metric | ANL | EPSM |
|---|---|---|
| Price | $8.06 | $1.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | 215.2K | ★ 270.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $1.04 |
| 52 Week High | $12.09 | $155.00 |
| Indicator | ANL | EPSM |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 52.29 |
| Support Level | $7.21 | $1.65 |
| Resistance Level | $9.98 | $2.35 |
| Average True Range (ATR) | 1.05 | 0.29 |
| MACD | -0.30 | 0.10 |
| Stochastic Oscillator | 26.87 | 35.93 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.